Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.51

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. LYB
6. TFII
7. LITE
8. NVT
9. SPY
10. RELIANCE:I

Go back to Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.51

Dr. Reddy’s Q3 and 9M FY16 Financial Results

February 9, 2016 4:55 AM EST

Q3 Revenues at Rs. 39.7 billion (YoY growth of 3%)
Q3 EBITDA at Rs. 10.1 billion (25.5% of the revenues)

9M Revenues at Rs. 117.1 billion (YoY growth of 7%)
9M EBITDA at Rs. 31.4 billion (26.8% of the revenues)

HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddys Laboratories Ltd. (NYSE: RDY | BSE: 500124 | NSE: DRREDDY) today announced its consolidated financial results for the quarter ended December 31, 2015 under International Financial Reporting Standards (IFRS).

Q3 FY16: Key Highlights

Consolidated revenues at Rs. 39.7 billion, year-on-year growth of 3%.... More